Inventiva Sa Stock Performance
| IVEVF Stock | USD 4.44 0.00 0.00% |
Inventiva holds a performance score of 9 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.06, which attests to a somewhat significant risk relative to the market. Inventiva returns are very sensitive to returns on the market. As the market goes up or down, Inventiva is expected to follow. Use Inventiva SA risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis , to analyze future returns on Inventiva SA.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Inventiva SA are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Inventiva reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 105.7 M | |
| Total Cashflows From Investing Activities | -1.8 M | |
| Free Cash Flow | -48.2 M |
Inventiva |
Inventiva Relative Risk vs. Return Landscape
If you would invest 228.00 in Inventiva SA on October 9, 2025 and sell it today you would earn a total of 216.00 from holding Inventiva SA or generate 94.74% return on investment over 90 days. Inventiva SA is currently producing 1.565% returns and takes up 12.8165% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Inventiva, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Inventiva Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inventiva's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Inventiva SA, and traders can use it to determine the average amount a Inventiva's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1221
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | IVEVF | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Inventiva is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inventiva by adding it to a well-diversified portfolio.
Inventiva Fundamentals Growth
Inventiva Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Inventiva, and Inventiva fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inventiva Pink Sheet performance.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.34 | |||
| Operating Margin | (6.37) % | |||
| Current Valuation | 108.8 M | |||
| Shares Outstanding | 42.13 M | |||
| Price To Book | 2.85 X | |||
| Price To Sales | 21.40 X | |||
| Revenue | 4.19 M | |||
| EBITDA | (48.96 M) | |||
| Cash And Equivalents | 76.72 M | |||
| Cash Per Share | 1.82 X | |||
| Total Debt | 8.74 M | |||
| Debt To Equity | 0.27 % | |||
| Book Value Per Share | 1.66 X | |||
| Cash Flow From Operations | (47.63 M) | |||
| Earnings Per Share | (1.33) X | |||
| Total Asset | 121.98 M | |||
About Inventiva Performance
By analyzing Inventiva's fundamental ratios, stakeholders can gain valuable insights into Inventiva's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Inventiva has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Inventiva has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis , mucopolysaccharidoses , and other diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. Inventiva is traded on OTC Exchange in the United States.Things to note about Inventiva SA performance evaluation
Checking the ongoing alerts about Inventiva for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Inventiva SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Inventiva SA is way too risky over 90 days horizon | |
| Inventiva SA appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 4.19 M. Net Loss for the year was (49.63 M) with profit before overhead, payroll, taxes, and interest of 7.48 M. | |
| Inventiva SA has accumulated about 76.72 M in cash with (47.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.82. | |
| Roughly 25.0% of the company shares are held by company insiders |
- Analyzing Inventiva's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inventiva's stock is overvalued or undervalued compared to its peers.
- Examining Inventiva's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inventiva's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inventiva's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inventiva's pink sheet. These opinions can provide insight into Inventiva's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Inventiva Pink Sheet analysis
When running Inventiva's price analysis, check to measure Inventiva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inventiva is operating at the current time. Most of Inventiva's value examination focuses on studying past and present price action to predict the probability of Inventiva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inventiva's price. Additionally, you may evaluate how the addition of Inventiva to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |